Funding · Company
Carmot Therapeutics Inc.
Berkeley, CABiotech & Pharma
Carmot Therapeutics Inc. of Berkeley, CA has disclosed $311M across 2 Form D offerings filed with the SEC between Aug 8, 2022 and Jun 6, 2023.
$311M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBerkeley, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001490109Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →